Cite
Learn from antibody–drug conjugates: consideration in the future construction of peptide-drug conjugates for cancer therapy.
MLA
Wu, Mo, et al. “Learn from Antibody–drug Conjugates: Consideration in the Future Construction of Peptide-Drug Conjugates for Cancer Therapy.” Experimental Hematology & Oncology, vol. 11, no. 1, Nov. 2022, pp. 1–18. EBSCOhost, https://doi.org/10.1186/s40164-022-00347-1.
APA
Wu, M., Huang, W., Yang, N., & Liu, Y. (2022). Learn from antibody–drug conjugates: consideration in the future construction of peptide-drug conjugates for cancer therapy. Experimental Hematology & Oncology, 11(1), 1–18. https://doi.org/10.1186/s40164-022-00347-1
Chicago
Wu, Mo, Wei Huang, Nan Yang, and Yanyong Liu. 2022. “Learn from Antibody–drug Conjugates: Consideration in the Future Construction of Peptide-Drug Conjugates for Cancer Therapy.” Experimental Hematology & Oncology 11 (1): 1–18. doi:10.1186/s40164-022-00347-1.